Delivery Order SPE2DB22D2206-SPE2DB25FJL03
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 27, 2025, for the supply of OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract is valued at $9,577.85 under a firm fixed-price arrangement with an ultimate completion date of June 30, 2025. This delivery order is not set-aside and represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $12,223.20 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. The contract, issued on September 9, 2025, with ultimate completion by September 10, 2025, utilizes firm fixed pricing under a non-set-aside, competitively awarded delivery order. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.30 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Gen 5 insulin infusion pods. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 4, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting federal medical supply chain requirements. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a $17,144.30 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitively awarded, firm fixed-price contract is scheduled for completion by July 31, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania facility. The delivery order carries no set-aside designation and represents a continuation of the company's extensive medical supply support to federal...
- The Defense Logistics Agency awarded a delivery order valued at $9,190.25 to AmerisourceBergen Drug Corp on September 4, 2025, for OmniPod 5 Dexcom G7 insulin delivery pods (Generation 5), with a completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device supplier to the federal government. The delivery will be fulfilled from the vendor's corporate office in...
- The Defense Logistics Agency awarded a $6,285.41 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods on September 2, 2025. This is a non-set-aside competitive award with an ultimate completion date of September 3, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $16,496.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, which is a non-set-aside award, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. Performance will be completed by September 11,...
- The Defense Logistics Agency awarded a delivery order valued at $9,551.50 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical and medical device procurement supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods valued at $1,222.32. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December...
- This delivery order, valued at $1,018.60, was awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025. This delivery order is a child...